Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 3/20 | 0.41 |
| ▸ | ATXN2 | Q99700 | 3/20 | 0.41 |
| ▸ | MGLL | Q99685 | 3/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | GPR183 | P32249 | 6/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.37 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30700371 | 0.86 | ENPP2 (0.43) | ENPP2ATXN2MGLLFAAHGPR183 | |
| SCHEMBL30700172 | 0.86 | ENPP2 (0.43) | ENPP2ATXN2MGLLFAAHGPR183 | |
| SCHEMBL30699993 | 0.83 | ENPP2 (0.42) | ENPP2ATXN2MGLLFAAHCYP3A4 | |
| SCHEMBL25253780 | 0.80 | FAAH (0.47) | ENPP2ATXN2MGLLFAAHGPR183 | |
| SCHEMBL30700370 | 0.79 | FAAH (0.44) | ENPP2ATXN2MGLLFAAHGPR183 | |
| SCHEMBL30700512 | 0.79 | FAAH (0.44) | ENPP2ATXN2MGLLFAAHGPR183 | |
| SCHEMBL31307999 | 0.79 | ENPP2 (0.41) | ENPP2ATXN2MGLLFAAHGPR183 | |
| SCHEMBL31308016 | 0.79 | ENPP2 (0.41) | ENPP2ATXN2MGLLFAAHGPR183 | |
| SCHEMBL30700573 | 0.79 | ENPP2 (0.41) | ENPP2ATXN2MGLLFAAHGPR183 | |
| SCHEMBL30700038 | 0.79 | MGLL (0.44) | ENPP2ATXN2MGLLCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543870-A1 | NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2025-04-30 | — | — | EP | claimed |
| CN-119301113-A | Novel heterocyclic carbonyl cyclic compounds as MAGL inhibitors | 豪夫迈·罗氏有限公司 | 2025-01-10 | — | — | CN | claimed |
| WO-2023247670-A1 | NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2023-12-28 | — | — | WO | claimed |
| CN-119301113-A | Novel heterocyclic carbonyl cyclic compounds as MAGL inhibitors | 豪夫迈·罗氏有限公司 | 2025-01-10 | — | — | CN | disclosed |
| WO-2023247670-A1 | NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2023-12-28 | — | — | WO | disclosed |